You might be right. I still reckon this stock does have the potential to climb past a dime on any given day though. How do we really know what is going on behind the scenes? The product seems to have support from plenty of people with scientific backgrounds that either are sold on it or do attest that it does appear promising. How much does the actual market it is being sold in and the present share price affect more investment from larger investors from big pharma or general scientific community? If I was flushed with cash ready to invest big dollars into a company, I wouldn't touch anything in this market! But if I had a neuroscience background and studied up on AMBS and MANF, might I feel more inclined to invest here? I do have a background in the pharmaceutical industry and I have seen lots of money thrown into researches and various projects that appear wasteful to me. Furthering MANF research seems like a worthy research to invest into IMO. This is why I have gambled already into MANF and hope to be able to gamble more when funds do come in!
News 
Market Data 
Discover 
AI
